ONK Therapeutics News:

Press Release 06th May. 2020

ONK Therapeutics and biotech company Avectas has signed a collaborative deal for Avectas to licence a therapy from ONK Therapeutics that targets blood cell cancers such as non-Hodgkin’s lymphoma and certain forms of leukaemia.
Read the full article here

Press Release 10th Dec. 2018

ONK Therapeutics announced as one of the 27 ground breaking projects to receive funding Under Disruptive Technologies Innovation Fund

Today, The Department for Business, Enterprise and Innovation through the Disruptive Technologies Innovation Fund announced that Galway based ONK Therapeutics Ltd, together with it’s consortium partners Janssen Sciences Ireland UC based in Cork and the Centre for Cell Manufacturing Ireland based at NUI Galway, are one of it’s 27 chosen projects to receive funding in order to further develop it’s research into the treatment of cancer, the second biggest killer of humans globally.
ONK Therapeutics is an NK cell therapy company focused on cancer treatment.  NK cells are one of the body’s strongest defences against cancer, being one of the most tumour cytotoxic components of the human immune system. ONK Therapeutics’s strategy is to develop novel, off the shelf, NK cell-based therapies for cancer. Further, the company is seeking to enhance these NK cells through the introduction of a series of genetic modifications, creating a technology platform that can be tailored to multiple cancers.
Following this morning’s announcement by An Taoiseach, Leo Varadkar TD and Minister for Business, Enterprise and Innovation, Heather Humphreys, Professor Michael O’Dwyer, Chief Scientific Officer of ONK Therapeutics welcomed the announcement and said that he looked forward to developing novel NK cell based therapeutics for cancer in collaboration with consortium partners, NUI Galway and Janssen.

For further information please contact:
Prof. Michael O’Dwyer
Founder & Director of ONK Therapeutics
Email: michael.odwyer@onktherapeutics.ie
Tel: +353 87 250 6638

We will be presenting two abstracts at the upcoming Annual Meeting of the American Society of Hematology (http://www.hematology.org).
For more information please see,

Industry News:

10th December 2018
An Taoiseach and Minister Humphreys announce over €75m for 27 groundbreaking projects under Disruptive Technologies Innovation Fund

  • Collaborative projects include household electricity generation, sepsis treatments, coastal flooding supports & medical 3D printing
  • Project Ireland 2040 fund allocating €500m over next 10 years
  • Key element of Government’s ‘Future Jobs’ initiative

An Taoiseach, Leo Varadkar TD, Minister for Business, Enterprise and Innovation, Heather Humphreys TD have unveiled the 27 innovative projects who are sharing over €75 million in funding out to 2021 under the first tranche of the Disruptive Technologies Innovation Fund.
Full text is article is available here

RSS Biotech News

RSS Pharma News